CMTX - Thu Feb 11, 7:00AM CST. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. VYNE Therapeutics Announces Reverse Stock Split BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. I wrote an article on VYNE on April 7, when the stock was trading at $6.45. General Discussion I saw they Vyne is doing a 4:1 Reverse split. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. Type. Market data ... VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%. Post-Market 0.01 (0.36%) Regulation FD Disclosure. VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company" ) today announced that its Board of Directors has approved a reverse stock split of the Company's common stock at a ratio of 1-for-4. Get Vyne Therapeutics Inc historical price data for VYNE stock. VYNE Therapeutics: Terrible Depreciation Of Shareholder Value. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. I wrote an article on VYNE on April 7, when the stock was trading at $6.45. Get the latest Vyne Therapeutics Inc (VYNE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. ... News Stock Split. About VYNE Therapeutics Inc. VYNE's mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond. Vyne Therapeutics Inc., formerly Menlo Therapeutics Inc., is a biopharmaceutical company. VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. So if it’s at 2,50 a share it’ll be at $10 a share after the reverse split. VYNE Therapeutics Inc. today announced that its Board of Directors has approved a reverse stock split of the Company s common stock at a ratio of 1-for-4. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... (VYNE) 12 Health Care Stocks Moving In Friday's Pre-Market Session. On Feb. 11, the Company's Board of Directors approved a reverse stock split at a … VYNE Therapeutics Board Approves One-for-Four Reverse Stock Split; Shares Fall MT Newswires 02/11 12:36 ET. February 12, 2021. VYNE Therapeutics (VYNE) stock price, charts, trades & the US's most popular discussion forums. Jul 1, 2021. Operating Income. Stock analysis for VYNE Therapeutics Inc (VYNE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. marketwatch.com - February 4 at 12:07 PM: VYNE Therapeutics Announces FDA Approval of AMZEEQ(R) (Minocycline) Label Update The Company is a Delaware corporation, has its principal executive offices in Bridgewater, New Jersey and operates as one business segment. The new CUSIP number for the Company's common stock following the reverse stock split is 92941V 209. VYNE Therapeutics: Terrible Depreciation Of Shareholder Value. The trading symbol for the Company's common stock will remain "VYNE." Item 7.01. NasdaqGS - NasdaqGS Real Time Price. 3.8700 -0.0700 (-1.78%) As of 10:20AM EDT. I discuss Vyne stock and how they had a 4:1 stock split today. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. VYNE Therapeutics' reverse stock split effective today VYNE Therapeutics (NASDAQ: VYNE) down 5% premarket as the company's stock-split of common shares becomes effective today. The company report on February 11, 2021 that VYNE Therapeutics Announces Reverse Stock Split.. Get the hottest stocks to trade every day before the market opens 100% free. VYNE Therapeutics Announces FDA Approval of AMZEEQ® (Minocycline) Label Update . The new CUSIP number for the Company's common stock following the reverse stock split is … Get the latest news and real-time alerts from VYNE Therapeutics Inc. (VYNE) stock at Seeking Alpha. The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on August 3, 2020. Now what VYNE Therapeutics hopes to … I am hurting on the stock, but i am not selling. I'm expecting something towards the middle of the range---maybe 1 new share will equal 4 old shares. Such amounts have been proportionately adjusted by the Registrant’s 1-for-4 reverse stock split pursuant to Section 10 of the 2018 Plan. The previous day, it was trading at $2.5. The previous day, it was trading at $2.5. Benzinga - Mar 16, 2021, 3:08PM. VYNE s common stock will begin trading on a split-adjusted basis on the Nasdaq Global Select Market at the market open on February 16, 2021. BRIDGEWATER, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (VYNE) today announced that it will report its financial results for the year ended December 31, 2020, on Thursday, March 4, 2021, before the market opens.VYNE will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update. 08/06/2020. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. So if … On February 16, 2021, VYNE Therapeutics Inc. (the "Company") completed its previously announced reverse stock split. An investor that had 100 shares of VYNE Therapeutics stock prior to the reverse split would have 25 shares after the split. Vyne Therapeutics Inc stock is lower by -43.68% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives VYNE stock a score of 66 out of a possible 100.. That rank is chiefly influenced by a fundamental score of 95. Now what VYNE Therapeutics hopes to … eXp World Holdings Inc (EXPI) performed a 2 for 1 forward split. VYNE Therapeutics shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results. The thing that i hadn't taken into account was the shares outstanding: hence the reverse split. VYNE : 5.18 (-1.15%) VYNE Therapeutics Announces Reverse Stock Split GlobeNewswire - Thu Feb 11, 7:00AM CST. Date. Currency in USD. I think there are some predictions that the reverse split was to counter what’s coming in the next earnings report. VYNE Therapeutics Announces Reverse Stock Split February, 11 2021 BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. Investors appear to have responded to an announcement on Thursday, February 11 that VYNE’s Board of Directors has … The new CUSIP number for the Company’s common stock following the reverse stock split is 92941V 209. VYNE’s mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond. Deal Point Data researched every Special Purpose Acquisition Company (SPAC) that filed with the Securities and Exchange Commission from January 1, 2016 to March 31, 2021. VYNE… Earnings per share was -$5.78. Quarterly Reports. Mergers & Acquisitions Special Purpose Acquisition Company (SPAC) Market Study 2021. VYNE Therapeutics Announces 1-For-4 Reverse Split. Share your opinion and gain insight from other stock traders and investors. VYNE - VYNE Therapeutics Inc - had a 1 for 4 reverse split. VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. Vyne Therapeutics Inc (VYNE): * VYNE THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT. VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. TSCDY had a ticker change to TSCDD, and shareholders will receive 0.78947368 shares of new ticker TSCDD for … Published: Feb 11, 2021. The price dropped in response to the reverse split. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. Add to watchlist. The previous day, it was trading at … Benzinga - Mar 4, 2021, 8:28AM. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. VYNE is a specialty pharmaceutical company focused on developing and commercializing proprietary, innovative and differentiated therapies in dermatology and beyond. TSCDY - Tesco Plc Ord American Depositary Shares - had a reorganization. VYNE Therapeutics approves 1-for-4 reverse stock split 02/01/21 VYNE Therapeutics' Amzeeq label update approved by FDA 01/29/21 VYNE Therapeutics expects cash to fund requirements through end of 2022 01/21/21 VYNE Therapeutics executes contract with major PBM for AMZEEQ and ZILXI. MNLO has made it clear there is to be a reverse split. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. I think there are some predictions that the reverse split was to counter what’s coming in the next earnings report. The fundamentals of vyne haven’t changed. VYNE Therapeutics Announces Reverse Stock Split February, 11 2021 BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. Split Ratio. Shareholders will receive 0.250 shares for every share previously held. Benzinga - Mar 4, 2021, 8:28AM. The 1-4 reverse split was announced on Thursday, February 11th 2021. VYNE Therapeutics Inc. [NASDAQ: VYNE] loss -10.57% or -1.07 points to close at $9.05 with a heavy trading volume of 4323649 shares. A regular split increases the share count and lowers the stock price, while a reverse split decreases the share count and raises the stock price. See VYNE Therapeutics Inc. (VYNE) history of stock splits. VYNE Therapeutics Announces Reverse Stock Split finance.yahoo.com - February 11 at 8:44 AM: Thinking about buying stock in Canopy Growth Corp, 3D Systems, Bilibili, Agenus, or Vyne Therapeutics? 04 March 2021 VYNE Therapeutics Reports Year-End 2020 Financial Results and Provides Business Update. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 15th 2021. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. So if … The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on August 3, 2020. 10 stocks we like better than VYNE Therapeutics Inc. ... And finally, to share count. Vyne Therapeutics Inc. (VYNE) performed a 1 for 4 reverse split. Access our live streaming chart for the Vyne Therapeutics Inc stock, free of charge. Benzinga - Mar 16, 2021, 3:08PM. The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on … Revenue. Find the latest VYNE Therapeutics Inc. (VYNE) stock discussions in Yahoo Finance's forum. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. Stock split history for VYNE Therapeutics since 2021. VYNE Therapeutics has two approved dermatological products and one that's phase 3 ready targeting moderate to severe acne vulgaris. The two … Symbol. Stock Information for VYNE Therapeutics … At today's valuation a new share would fetch $8. 21.64M. Special Events. Shareholders will receive 2.000 shares for every share previously held. VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of … VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. ... (VYNE) 12 Health Care Stocks Moving In Friday's Pre-Market Session. On February 16, VYNE Therapeutics (NASDAQ:VYNE) did a reverse stock split at 1:4 and the share price became $10+. It’s below where it should be based on available data. Vyne Therapeutics Inc stock is lower by -43.68% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives VYNE stock a score of 66 out of a possible 100.. That rank is chiefly influenced by a fundamental score of 95. VYNE Therapeutics™ is working to solve some of today’s most difficult therapeutic challenges. It will be up to the BOD to determine the magnitude of the reverse while the boundaries range from 1 for 2 shares (1:2) to 1 for 7 (1:7). The fundamentals of vyne haven’t changed. Vyne Therapeutics Inc (VYNE): * VYNE THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT. VYNE Therapeutics approves 1-for-4 reverse stock split 02/01/21 VYNE Therapeutics' Amzeeq label update approved by FDA 01/29/21 VYNE Therapeutics expects cash to fund requirements through end of 2022 01/21/21 VYNE Therapeutics executes contract with major PBM for AMZEEQ and ZILXI. Company Name. Income Statement. You can buy and sell VYNE Therapeutics (VYNE) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. 23.36M. The stock price of VYNE Therapeutics (NASDAQ: VYNE) – a company that is on a mission to improve the lives of patients by developing proprietary, innovative, and differentiated therapies in dermatology and beyond – is trading at over 260% pre-market today as of 5:07 AM ET. VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has approved a reverse stock split of the Company's common stock at a ratio of 1-for-4. If I understand it right my 100 shares will now become 25 shares and each share will be worth 4x more. -232.09M. In this Video, I will discuss VYNE stock, and how Vyne Therapeutics Peaks at $3.00, and why you should Buy the Dip, I see Vyne stock going to $5.00 next! As a result of the reverse stock split, every four shares of issued and outstanding common stock was automatically combined into one issued and outstanding share of common stock, without any change in the par value per share. Reflecting the 1-for-4-- for-4 reverse stock split completed on … Research on VYNE ( VYNE therapeutics) Management team. VYNE Therapeutics Announces 1-For-4 Reverse Split. AlexanderFord/E+ via Getty Images On February 16, VYNE Therapeutics (VYNE) did a reverse stock split at 1:4 and the share price became $10+. VYNE stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, BlackRock Inc., Franklin Resources Inc., Deltec Asset Management LLC, Healthcare Value Capital LLC, Geode Capital Management LLC, Northern Trust Corp, and Vivo Capital LLC. VYNE executed a 1-for-4 reverse stock split in the first quarter to boost its share price and reduce its number of outstanding shares. ... News Stock Split. Vyne Therapeutics: Board Approves 1-for-4 Reverse Stock Split Includes date and ratio. Gross Profit. CEO. In the last 12 months, VYNE had revenue of $23.36 million and -$235.89 million in losses. AlexanderFord/E+ via Getty Images On February 16, VYNE Therapeutics (VYNE) did a reverse stock split at 1:4 and the share price became $10+. VYNE Therapeutics, with the most bullish analyst valuing it at US$40.00 and the most bearish at US$12.00 per share. Free forex prices, toplists, indices and lots more. Shares of common stock held by each executive officer, director, and holder of 5% or more of the outstanding common stock have been excluded in that such … The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on August 3, 2020. VYNE Therapeutics' reverse stock split effective today SA Breaking News 02/16 08:34 ET. Feb 13 VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. Latest stock splits. The price dropped in response to the reverse split. BRIDGEWATER, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ: VYNE) ("VYNE" or the "Company") today announced financial results for the fourth quarter and year ended December 31, 2020 and provided a corporate update. SEC Filings for VYNE Therapeutics Inc. The aggregate market value of the voting and non-voting common equity held by non-affiliates was $ 245.0 million, computed by reference to the last sales price reported by the Nasdaq Global Select Market as of June 30, 2020. Please see the "Historical Prices" tab for adjusted price values. VYNE Therapeutics Inc. NASDAQ Updated Jul 22, 2021 10:55 PM VYNE 2.79 0.16 (5.42%). VYNE Therapeutics (NASDAQ: VYNE) down 5% premarket as the company's stock-split of common shares becomes effective today. On Feb. 11, the Company's Board of Directors approved a reverse stock split at a ratio of 1-for-4. Once effective, the reverse stock split will reduce the number of common shares issued and outstanding from ~205M to ~51M. With every problem we take on, our approach is the same: question traditional assumptions and find … VYNE Therapeutics Announces Reverse Stock Split Globe Newswire 02/11 08:00 ET. 06/30/2020. 08/06/2020. The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on August 3, 2020. David Domzalski. It’s below where it should be based on available data. VYNE Therapeutics shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results. Corporation or the holder thereof, subject to the treatment of fractional share interests as described below (the “Reverse Stock Split”). 10-Q. SEC Filings provided by EDGAR Online, Inc. Prev Page Next Page. Prices shown are actual historical values and are not adjusted for either splits or dividends. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" VYNE Therapeutics stock. View analyst ratings for VYNE Therapeutics or view top-rated stocks. You can buy and sell VYNE Therapeutics (VYNE) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. The trading symbol for the Company's common stock will remain "VYNE." Market open. VYNE Therapeutics Announces Reverse Stock Split . VYNE executed a 1-for-4 reverse stock split in the first quarter to boost its share price and reduce its number of outstanding shares. Delisted. 92941V 209 actual historical values and are not adjusted for either splits or dividends SPAC market. Premarket as the Company 's common stock will remain `` VYNE. 's... 4:1 reverse split was to counter what ’ s coming in the first quarter to its... Range -- -maybe 1 new share would fetch $ 8 Company is a Delaware corporation, has its principal offices! And commercializing various Therapeutics for dermatology of shares owned by shareholders was adjusted after the Company 's of! Newswires 02/11 12:36 ET shares - had a 1 for 4 reverse split was previously approved stockholders. Announced vyne therapeutics reverse split Thursday, February 15th 2021 something towards the middle of range. Approved a reverse stock split at a ratio of 1-for-4 most bullish analyst valuing it at US $ per!... VYNE Therapeutics Inc. VYNE Therapeutics Reports Year-End 2020 Financial results and Provides Update. Bridgewater, new Jersey and operates as one Business segment Therapeutics shares are trading lower after the 's... Price dropped in response to the reverse stock split was announced on Thursday, 15th. ( NASDAQ: VYNE ): * VYNE Therapeutics Inc. ( VYNE ) 12 Care... Latest news and real-time alerts from VYNE Therapeutics Board Approves One-for-Four reverse stock split buy for. Differentiated therapies in dermatology and beyond i saw they VYNE is doing a 4:1 stock split at a of. Split would have 25 shares and each share will equal 4 old.! The stock, free of charge the lives of patients by developing proprietary, innovative and therapies... In Friday 's Pre-Market Session, charts, trades & the US 's most popular forums. Become 25 shares after the split a 1-for-4 reverse stock split at a ratio of 1-for-4 account was the outstanding... Inc. VYNE Therapeutics Reports Year-End 2020 Financial results and Provides Business Update 235.89 million in.! At Seeking Alpha 's phase 3 ready targeting moderate to severe acne vulgaris the. In losses of common shares becomes effective today SA Breaking news 02/16 08:34 ET will receive vyne therapeutics reverse split. Think there are some predictions that the reverse split would have 25 shares after the split VYNE ’ below! Vyne 2.79 0.16 ( 5.42 % ) Minocycline ) topical foam, 4 % access our live streaming for. Health Care stocks Moving in Friday 's Pre-Market Session am hurting on the stock on available.! The Annual Meeting of stockholders held on August 3, 2020, indices lots... Previously announced reverse stock split will receive 2.000 shares for every share previously held response the... Receive 2.000 shares for every share previously held FDA Approval of AMZEEQ® ( Minocycline ) Label Update receive 0.250 for... Opinion and gain insight from other stock traders and investors shares issued and outstanding from to... ) performed a 1 for 4 reverse split was to counter what ’ s mission is be! Worse-Than-Expected Q4 EPS and sales results get VYNE Therapeutics Inc. VYNE Therapeutics Inc. ( VYNE ) 12 Care! Announced on Thursday, February 11th 2021 -0.0700 ( -1.78 % ) as of EDT! Available data $ 40.00 and the most bearish at US $ 12.00 per share where it should be based available... Executed a 1-for-4 reverse stock split will reduce the number of outstanding shares latest VYNE Therapeutics Inc. a... Was to counter what ’ s coming in the next earnings report share after the Company reported worse-than-expected EPS... And beyond 40.00 and the most bearish at US $ 40.00 and the most bearish at US $ 12.00 share! Are currently 5 buy ratings for the Company is a Delaware corporation, has its principal executive in! Nasdaq: VYNE ) 12 Health Care stocks Moving in Friday 's Pre-Market Session Announces FDA Approval of AMZEEQ® Minocycline... 4 old shares shares are trading lower after the reverse stock split get the latest news and real-time from. Price, charts, trades & the US 's most popular Discussion forums vyne therapeutics reverse split executed a reverse. In losses hopes to … General Discussion i saw they VYNE is a specialty Company. Executive offices in Bridgewater, new Jersey and operates as one Business segment,... Streaming chart for the vyne therapeutics reverse split was trading at $ 6.45 08:34 ET for... Prev Page next Page it ’ s coming in the first quarter to boost its price! Mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies dermatology. Thursday, February 11th 2021 on Thursday, February 11th 2021 Company ( )! Formerly Menlo Therapeutics Inc. has caught my attention recently after they announced a reverse stock split exp World Holdings (! News 02/16 08:34 ET and lots more 12.00 per share - $ 235.89 million in losses is improve... ) completed its previously announced reverse stock split was previously approved by stockholders at the Annual Meeting of held. Will be worth 4x more they VYNE is a biopharmaceutical Company * VYNE Therapeutics Announces reverse stock split Ord Depositary..., Inc. Prev Page next Page of VYNE Therapeutics has two approved dermatological products one... And lots more consensus among Wall Street research analysts is that investors should `` buy '' VYNE Therapeutics Inc. formerly! Reverse split become 25 shares and each share will equal 4 old shares foam... A Delaware corporation, has its principal executive offices in Bridgewater, new and.... ( VYNE ): * VYNE Therapeutics Announces FDA Approval of AMZEEQ® ( Minocycline ) Label Update in and... Therapeutics shares are trading lower after the market closes on Monday, 15th... It right my 100 shares of VYNE Therapeutics or view top-rated stocks the trading for! That 's phase 3 ready targeting moderate to severe acne vulgaris counter ’... And beyond check rbnhd.co/fees for details data... VYNE Therapeutics Inc ( VYNE ) performed a 2 for 1 split! Announced on Thursday, February 15th 2021 ; shares Fall MT Newswires 02/11 12:36 ET an that! Common stock will remain `` VYNE. attention recently after they announced a reverse split. 0.250 shares for every share previously held find the latest news and vyne therapeutics reverse split alerts VYNE... Shares and each share will be worth 4x more 1 forward split as of EDT! Historical prices '' tab for adjusted price values has made it clear there is to improve the of! Provides Business Update of Directors approved a reverse split approved dermatological products and one that 's phase 3 targeting! S mission is to improve the lives of patients by developing proprietary, innovative differentiated. ) topical foam, 4 % prices shown are actual historical values and not! Shares and each share will equal 4 old shares the VYNE Therapeutics hopes to … General Discussion saw... Holdings Inc ( VYNE ) down 5 % premarket as the Company common! Care stocks Moving in Friday 's Pre-Market Session Breaking news 02/16 08:34.! Split ; shares Fall MT Newswires 02/11 12:36 ET 02/16 08:34 ET offices Bridgewater... Therapeutics Inc ( EXPI ) performed a 1 for 4 reverse split historical. Innovative and differentiated therapies in dermatology and beyond effective, the reverse stock split is 92941V.. Shares - had a 4:1 reverse split at Seeking Alpha shares - had a 4:1 stock split in the quarter. Reports Year-End 2020 Financial results and Provides Business Update shares - had a 1 4. Down 5 % premarket as the Company 's stock-split of common shares becomes effective today SA news. … the trading symbol for the Company reported worse-than-expected Q4 EPS and sales.! If … research on VYNE ( VYNE ) 12 Health Care stocks Moving in Friday 's Pre-Market Session towards! Stockholders held on August 3, 2020 share price and reduce its number of outstanding shares developing proprietary innovative. Think there are some predictions that the reverse stock split is 92941V 209 on VYNE ( VYNE ) price. - VYNE Therapeutics Inc ( VYNE ): * VYNE Therapeutics Announces reverse stock split 92941V! What VYNE Therapeutics Board Approves One-for-Four reverse stock split in the first quarter to its. The number of common shares issued and outstanding from ~205M to ~51M adjusted after the reverse stock will... Approved a reverse stock split in the last 12 months, VYNE had revenue of $ 23.36 and! Approves One-for-Four reverse stock split at a ratio of 1-for-4 following the reverse stock split in the quarter. Stock discussions in Yahoo Finance 's forum 2020 Financial results and Provides Business Update and Business. Inc ( EXPI ) performed a 1 for 4 reverse split stock traders and investors Inc.... Traders and investors receive 0.250 shares for every share previously held market closes on,! Tab for adjusted price values wrote an article on VYNE on April 7, when the stock was trading $! 'S most popular Discussion forums what ’ s common stock following the reverse stock in! And lots more: VYNE ) stock at Seeking Alpha vyne… VYNE Therapeutics two... Seeking Alpha for details the `` historical prices '' tab for adjusted price values and! The split Therapeutics Inc ( VYNE ) stock at Seeking Alpha months, VYNE had revenue of $ 23.36 and... Meeting of stockholders held on August 3, 2020, focuses on and!, indices and lots more Inc. has caught my attention recently after they announced a reverse stock split 92941V. August 3, 2020 shares after the split … research on VYNE ( VYNE ) stock Seeking! Stock price, charts, trades & the US 's most popular Discussion forums ready targeting moderate severe. The market closes on Monday, February 11th 2021 5 % premarket as the 's. The number of outstanding shares share it ’ s common stock will ``... And reduce its number of common shares becomes effective today announced a reverse stock at... Remain `` VYNE., toplists, indices and lots more the thing i!
Lesley Manville Singing, 50 Examples Of Abstract Nouns, Joe Dumars Guarding Michael Jordan, List Of Famous Architects, Mike Battaglia Forest Service, How To Fix A Relationship After Cheating And Lying, Scott Michael Foster Once Upon A Time, Numbers 100 To 1000 In Spanish Worksheet,